Researchers at Sanford Burnham Prebys Medical Discovery Institute (CA, USA) have published a study shedding new light on how the anti-cancer agent K-80003 (TX803) inhibits cancer cell growth.
Browsing: protein interaction
A pro-metastatic protein interaction has been identified in lung cancer and could present a potential future target.
Researchers demonstrate that ubiquitination modification is a constitutive component of cancer growth-regulating proteins, indicating a new avenue for therapeutics.
Scientists at The Institute of Cancer Research have mapped out potential cancer drug targets using a protein social network model.
A team of researchers at the National University of Singapore (NUS) have discovered that the interaction between two proteins, namely FAT10 (diubiquitin) and mitotic arrest deficient 2 (MAD2), lead to inflammation-associated cancers, such as hepatocellular carcinoma and colorectal cancers.